Co-culture with hPreAd and treatment with IL-6 promoted the migration and proliferation ability of DCIS.com, whereas treatment with IL-6 NAb or IL-6R NAb abrogated the DCIS.com migration and proliferation enhanced by co-culture with hPreAd. The gene discussed is IL6R; the disease is ductal breast carcinoma in situ.